And thats why the Chief Medical Officer was appointed... hoping for a smooth outcome for the remainder of the trial/phase II and Phase III.
Ann: ACCENT Trial Achieves Superiority over Chemotherapy Alone, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $91.57M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 23.3¢ | $296.8K | 1.258M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 347830 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 678591 | 13 |
View Market Depth
| Last trade - 11.28am 29/07/2025 (20 minute delay) ? |
| ATX (ASX) Chart |